nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cart in search of a horse
|
Altschuler, Yoram |
|
2002 |
23 |
6 |
p. 296-297 2 p. |
artikel |
2 |
A cellular cofactor in HIV-1 assembly: INI1 is also an ‘outtie’
|
Landau, Nathaniel R |
|
2002 |
23 |
6 |
p. 252-253 2 p. |
artikel |
3 |
A model for the functioning of family 3 GPCRs
|
Parmentier, Marie-Laure |
|
2002 |
23 |
6 |
p. 268-274 7 p. |
artikel |
4 |
Can ‘real-lab’ supersede ‘virtual-ligand’ promises?
|
Wiseman, Alan |
|
2002 |
23 |
6 |
p. 261- 1 p. |
artikel |
5 |
Cation–π interactions in ligand recognition and catalysis
|
Zacharias, Niki |
|
2002 |
23 |
6 |
p. 281-287 7 p. |
artikel |
6 |
De novo design of biomimetic antimicrobial foldamers
|
Cuccia, Louis |
|
2002 |
23 |
6 |
p. 257-258 2 p. |
artikel |
7 |
Does insulin dysfunction play a role in Alzheimer's disease?
|
Gasparini, Laura |
|
2002 |
23 |
6 |
p. 288-293 6 p. |
artikel |
8 |
Human congenital long QT syndrome: more than previously thought?
|
Attali, Bernard |
|
2002 |
23 |
6 |
p. 249-251 3 p. |
artikel |
9 |
Immunogenicity of rDNA-derived pharmaceuticals
|
Ryff, Jean-Charles |
|
2002 |
23 |
6 |
p. 254-256 3 p. |
artikel |
10 |
In Brief
|
Cutler, David |
|
2002 |
23 |
6 |
p. 258-259 2 p. |
artikel |
11 |
Is DOPA a neurotransmitter?
|
Misu, Yoshimi |
|
2002 |
23 |
6 |
p. 262-268 7 p. |
artikel |
12 |
Teaching of pharmacology in the 21st century: new challenges and opportunities
|
Baños, Josep-E. |
|
2002 |
23 |
6 |
p. 294-296 3 p. |
artikel |
13 |
The ligand paradox between affinity and efficacy: can you be there and not make a difference?
|
Kenakin, Terry |
|
2002 |
23 |
6 |
p. 275-280 6 p. |
artikel |
14 |
The pressing need for combined genotype–phenotype analysis in clinical practice
|
Sapone, Andrea |
|
2002 |
23 |
6 |
p. 260-261 2 p. |
artikel |
15 |
Toll-like receptors: new therapeutic targets for autoimmune diseases
|
O'Neill, Luke A.J |
|
2002 |
23 |
6 |
p. 257- 1 p. |
artikel |